Vista Pharmaceuticals Ltd.
| BSE: 524711 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE427C01021 |
| BSE 00:00 | 24 Jun | 7.04 |
-0.11 (-1.54%) |
OPEN
7.40 |
HIGH
7.40 |
LOW
6.87 |
| NSE 05:30 | 01 Jan | Vista Pharmaceuticals Ltd |
| OPEN | 7.40 |
| PREVIOUS CLOSE | 7.15 |
| VOLUME | 27308 |
| 52-Week high | 15.97 |
| 52-Week low | 6.51 |
| P/E | |
| Mkt Cap.(Rs cr) | 26 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Vista Pharmaceuticals Ltd. (VISTAPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 526.40 | 9.05 | 1.75 | 15823.68 |
| Cipla | 933.40 | 0.40 | 0.04 | 13900.58 |
| Dr Reddy's Labs | 4308.75 | 12.55 | 0.29 | 13349.10 |
| Sun Pharma.Inds. | 824.10 | -0.60 | -0.07 | 12803.21 |
| Lupin | 629.95 | 0.95 | 0.15 | 11055.93 |
| Apollo Hospitals | 3835.60 | -14.95 | -0.39 | 9153.00 |
| Zydus Lifesci. | 353.70 | 7.55 | 2.18 | 7790.40 |
| Glenmark Pharma. | 383.75 | 6.90 | 1.83 | 7567.93 |
| Alkem Lab | 3003.85 | -34.80 | -1.15 | 7219.68 |
| Divi's Lab. | 3680.40 | 13.80 | 0.38 | 6798.61 |
| Torrent Pharma. | 2875.50 | 21.00 | 0.74 | 6450.83 |
| Ipca Labs. | 888.95 | -6.80 | -0.76 | 5114.11 |
| Alembic Pharma | 726.10 | 1.65 | 0.23 | 5051.44 |
| Laurus Labs | 466.60 | 7.00 | 1.52 | 4707.04 |
| Abbott India | 18088.00 | 61.50 | 0.34 | 4310.02 |
| Gland Pharma | 2643.70 | 36.60 | 1.40 | 3462.88 |
| Glaxosmi. Pharma | 1499.75 | -0.90 | -0.06 | 3193.74 |
| Granules India | 256.65 | 12.20 | 4.99 | 3134.98 |
| Sanofi India | 6410.00 | -80.10 | -1.23 | 2956.60 |
| Ajanta Pharma | 1249.85 | 36.00 | 2.97 | 2718.59 |
Quick Links for Vista Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
